Volume 66, Issue 1, Pages (July 2004)

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Volume 54, Issue 2, Pages (August 1998)

Volume 62, Issue 3, Pages (September 2002)

Chronic Pain in End-Stage Renal Disease

Beta blockers in the management of chronic kidney disease

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

End-stage renal disease in developing countries

Volume 83, Issue 3, Pages (March 2013)

C-reactive protein and dialysis access

Volume 55, Issue 2, Pages (February 1999)

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,

Volume 62, Issue 3, Pages (September 2002)

C-reactive protein and dialysis access

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

G protein β3 subunit C825T polymorphism in primary IgA nephropathy

John P. Middleton, Patrick H. Pun Kidney International

Burden of chronic kidney disease: North Africa

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Chronic Pain in End-Stage Renal Disease

Volume 58, Issue 1, Pages (July 2000)

Jeffrey C. Fink, Glenn M. Chertow Kidney International

End-stage renal disease in living kidney donors

Volume 71, Issue 2, Pages (January 2007)

C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Per-Ola Attman, M.D, Petar Alaupovic, Ola Samuelsson

N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment Martina Franz, Wolfgang Woloszczuk, Walter.

Volume 70, Issue 11, Pages (December 2006)

Joseph W. Eschbach, John W. Adamson Kidney International

Study of Heart and Renal Protection (SHARP)

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Relationship between methylmalonic acid and cobalamin in uremia

Elke Wühl, Otto Mehls, Franz Schaefer Kidney International

Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House

Fructose intake as a risk factor for kidney stone disease

Volume 73, Issue 12, Pages (June 2008)

Volume 76, Issue 6, Pages (September 2009)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Alternate-day dialysis may be needed for hemodialysis patients

Cardiovascular disease in pediatric chronic dialysis patients

Volume 58, Issue 2, Pages (August 2000)

Volume 62, Issue 6, Pages (December 2002)

Arjang Djamali, Christina Kendziorski, Peter C. Brazy, Bryan N. Becker

Terry Behrend, Steven B. Miller, M.D Kidney International

Volume 56, Issue 1, Pages (July 1999)

Homocysteine, renal function, and risk of cardiovascular disease

Volume 64, Issue 2, Pages (August 2003)

Long-term survival in renal transplant recipients with graft function

Wei-Teing Chen, Horng-Chin Yan, Fu-Chiu Yu Kidney International

Organ transplantation goes to the movies

The Iranian model of living renal transplantation

Volume 72, Issue 2, Pages (July 2007)

The Danish Renal Biopsy Register

Volume 80, Issue 10, Pages (November 2011)

Volume 65, Issue 4, Pages (April 2004)

Is it the low-protein diet or simply the salt restriction?

Is complement a target for therapy in renal disease?

Volume 70, Issue 5, Pages (September 2006)

Volume 75, Issue 7, Pages (April 2009)

Antioxidant therapy in hemodialysis patients: a systematic review

Volume 67, Issue 1, Pages (January 2005)

Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis Nauman Siddiqi, Maureen A. McBride,

Volume 57, Issue 4, Pages (April 2000)

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Presentation transcript:

Volume 66, Issue 1, Pages 338-347 (July 2004) Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein Martin Busch, Sybille Franke, Andreas Müller, Marco Wolf, Jens Gerth, Undine Ott, Toshimitsu Niwa, Günter Stein Kidney International Volume 66, Issue 1, Pages 338-347 (July 2004) DOI: 10.1111/j.1523-1755.2004.00736.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Serum levels of advanced glycation end products (AGEs), total homocysteine (tHcy), and metabolites at baseline of 99 patients with chronic renal failure (CRF), 84 hemodialysis patients (HD), and 49 patients after renal transplantation (RTR), mean, SD, median (—), respectively. Abbreviations are: CML, Nε-carboxymethyllysine; CYSTA, cystathionine; MMA, methylmalonic acid; 2-MCAtotal, total 2-methylcitric acid. Kidney International 2004 66, 338-347DOI: (10.1111/j.1523-1755.2004.00736.x) Copyright © 2004 International Society of Nephrology Terms and Conditions